Keros Therapeutics, Inc. · NASDAQ:KROS

ADAR1 Capital Management, LLC reported a 13.29% stake in Keros Therapeutics, Inc. (Schedule 13D)

Event Apr 4, 2025 · Filed Apr 11, 2025

ADAR1 Capital Management, LLC reported a 13.29% stake in Keros Therapeutics, Inc., 5,390,964 shares, with active intent on Apr 4, 2025. Filed Apr 11, 2025 (Schedule 13D).

Stake
13.29%
Shares
5,390,964
Intent
Active
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC13.29%5,390,964
ADAR1 Capital Management GP, LLC11.46%4,647,406
Daniel Schneeberger13.29%5,390,964

Source

View original at SEC

Related